Search

Search Constraints

You searched for: Author/Creator Kitade, Mitsuteru Subject 616.362

Search Results

1. Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Issue 9 (29th May 2019)

2. Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis. Issue 10 (15th July 2019)

3. Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis. Issue 12 (13th February 2017)

4. Dual blockade of angiotensin‐II and aldosterone suppresses the progression of a non‐diabetic rat model of steatohepatitis. Issue 7 (20th November 2012)

5. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. Issue 7 (10th June 2020)

6. Identification of clinical risk factors for histological progression of primary biliary cholangitis. Issue 9 (14th June 2019)

7. Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis. Issue 3 (21st July 2016)

8. Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis. Issue 3 (20th July 2017)

9. Predictive parameter of tolvaptan effectiveness in cirrhotic ascites. Issue 9 (9th November 2016)

10. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Issue 2 (9th October 2018)